ABSTRACT
Introduction
Heart failure (HF) remains a leading cause of cardiovascular (CV) mortality in patients with CV disease. The point-of-care (POC) HF platform seems to be an ideal noninvasive workflow-adapted system for personally adjusted management of patients with HF.
Areas covered
In the present manuscript, we reviewed the literature covering some relevant studies regarding the role of point-of care heart failure platform in the risk stratification, earlier diagnosis and prognostically beneficial treatment of patients with different phenotypes of HF.
Expert opinion
POC HF platform including personal consultation, optimization of the comorbidity treatment, step-by-step HF diagnostic algorithm, single biomarker measurements, has also partially been provided in the current guidelines. Although there are several obstacles to implement POC in routine practice, such as education level, aging, affordability of health care, even partial implementation of POC can also improve clinical outcomes. POC seems to be an evolving model, more research studies are required to clearly see whether it helps to make better decisions with diagnosis and care of HF, as well helps to achieve better clinical outcomes.
In summary, the POC HF platform is considered to be a more effective tool than conventional algorithm of HF management.
Abbreviations
ACC | = | American College of Cardiology |
AHA | = | American Heart Association |
CV | = | cardiovascular |
ESC | = | European Society of Cardiology |
ELISA | = | Enzyme-Linked Immunosorbent Assay |
GDMT | = | guideline-directed medical therapy |
HBTR | = | home-based tele-rehabilitation |
HF | = | heart failure |
HFpEF | = | heart failure with preserved ejection fraction |
HFrEF | = | heart failure with reduced ejection fraction |
LVEF | = | left ventricular ejection fraction |
MRA | = | mineralocorticoid receptor antagonist |
NICE | = | the UK National Institute for Health and Care Excellence |
POC | = | point-of care |
6MWD | = | 6-minute walking distance |
Article highlights
Guideline-directed medical therapy of HF seems to show poor adherence of the patients in routine clinical practice.
The point-of-care HF platform is a potentially effective personal strategy for improved management of patients with HF.
The point-of-care HF platform configures economically reasonable approaches for screening, diagnosis and therapy.
Biomarker-guided HF management is a powerful part of the point-of-care platform toward improved prognosis.
Declaration of interest
The authors have no other financial interest or financial conflict with the subject matter or materials that are discussed in the paper.
Reviewer disclosures
Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.